A technology has been developed that can screen for lung cancer at an early stage using exhaled breath. This technology demonstrated 95% accuracy in clinical settings. It is expected to contribute to ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers ...

Electronic nose breath analysis achieved 80-92% accuracy for detecting lung cancer in patients with suspicious findings. Detection accuracy remained consistent across tumor characteristics, disease ...

Lung cancer screening in high-risk never-smokers with artificial intelligence (LC-SHIELD study). Hypofraction radiotherapy followed by immune checkpoint inhibitors for locally advanced non-small cell ...

Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...